Comparative Pharmacology
Head-to-head clinical analysis: IMAGENT versus OPTISON.
Peer-Reviewed Evidence
Head-to-head clinical analysis: IMAGENT versus OPTISON.
IMAGENT vs OPTISON
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Imagent is a microbubble-based ultrasound contrast agent. It consists of perflutren (octafluoropropane) gas-filled microbubbles stabilized by phospholipids. The microbubbles oscillate and increase echogenicity in blood, enhancing ultrasound signal and imaging of cardiac structures and blood flow. Its mechanism does not involve active pharmacological action but rather physical acoustic enhancement.
OPTISON consists of perflutren protein-type A microspheres that act as an ultrasound contrast agent by increasing the echogenicity of blood, improving the visualization of cardiac chambers and intracardiac blood flow.
0.1 mL/kg intravenous bolus over 1-2 seconds, up to a maximum of 10 mL. Repeat dose once if needed after 30 minutes.
0.5 mL intravenous bolus; may repeat with additional 0.5 mL dose if needed. Administer via peripheral intravenous line at 1 mL/sec.
None Documented
None Documented
Terminal elimination half-life is 1.2 hours in patients with normal renal function; prolonged in renal impairment (up to 8 hours in severe impairment).
Plasma half-life of perfluoropropane gas is approximately 2.4 minutes after intravenous administration, with rapid equilibration and elimination via the lungs.
Primarily renal excretion (95% unchanged via glomerular filtration); minimal biliary/fecal (<5%).
Primarily eliminated via pulmonary excretion of the perfluoropropane gas; <1% renal excretion of the intact microsphere components.
Category C
Category C
Ultrasound Contrast Agent
Ultrasound Contrast Agent